Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis

The Rho kinase (ROCK) inhibitor Fasudil is a promising drug for a disease-modifying therapy of amyotrophic lateral sclerosis (ALS). In preclinical models, Fasudil was shown to increase motor neuron survival, inhibit axonal degeneration, enhance axonal regeneration and modulate microglial function in...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Jan C., Kuttler, Josua, Maass, Fabian, Lengenfeld, Teresa, Zielke, Eirini, Bähr, Mathias, Lingor, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083210/
https://www.ncbi.nlm.nih.gov/pubmed/32231638
http://dx.doi.org/10.3389/fneur.2020.00173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083210/
https://www.ncbi.nlm.nih.gov/pubmed/32231638
http://dx.doi.org/10.3389/fneur.2020.00173

Ejemplares similares